|
SNP/group
|
Genotype
|
χ2
|
p
|
OR (95% CI)
|
|---|
|
rs1867624
|
|
Dominant
|
TT + CT
|
CC
| | | |
|
Case
|
161 (0.40)
|
240 (0.60)
|
1.71
|
0.192
|
1.21 (0.91–1.61)
|
|
Control
|
146 (0.36)
|
263 (0.64)
| | |
|
Recessive
|
TT
|
CT + CC
| | | |
|
Case
|
28 (0.07)
|
373 (0.93)
|
2.52
|
0.112
|
1.63 (0.89–2.98)
|
|
Control
|
18 (0.04)
|
391 (0.96)
| | |
|
rs2057482
|
|
Dominant
|
TT + CT
|
CC
| | | |
|
Case
|
149 (0.37)
|
252 (0.63)
|
0.52
|
0.47
|
1.11 (0.83–1.48)
|
|
Control
|
142 (0.35)
|
267 (0.65)
| | | |
|
Recessive
|
TT
|
CT + CC
| | | |
|
Case
|
17 (0.04)
|
384 (0.96)
|
0.57
|
0.45
|
0.78 (0.41–1.49)
|
|
Control
|
22 (0.05)
|
387 (0.95)
| | | |
|
rs3739998
|
|
Dominant
|
CC + GC
|
GG
| | | |
|
Case
|
152 (0.38)
|
249 (0.62)
|
0.13
|
0.722
|
0.95 (0.71–1.26)
|
|
Control
|
160 (0.39)
|
249 (0.61)
| | |
|
Recessive
|
CC
|
GC + GG
| | | |
|
Case
|
20 (0.05)
|
381 (0.95)
|
0.31
|
0.580
|
0.84 (0.46–1.55)
|
|
Control
|
24 (0.06)
|
385 (0.94)
| | |
- SNP single nucleotide polymorphism, MI myocardial infarction
